Cipla Limited (BOM:500087)
India · Delayed Price · Currency is INR 1,353.85
-1.95 (-0.14%)
At close: Jun 19, 2026
Cipla Market Cap
Cipla has a market cap or net worth of 1.14 trillion as of June 22, 2026. Its market cap has decreased by -3.69% in one year.
Market Cap
1.14T
Enterprise Value
1.05T
Revenue
278.28B
Ranking
n/a
PE Ratio
29.48
Stock Price
1,353.85
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.14T, an increase of 75,450.09%. That is a compound annual growth rate of 24.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 1.14T | -6.32% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.86% |
| Dec 30, 2022 | 868.44B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.50T |
| Lupin | 1.08T |
| Dr. Reddy's Laboratories | 1.06T |
| Abbott India | 557.17B |
| GlaxoSmithKline Pharmaceuticals | 395.20B |
| J. B. Chemicals & Pharmaceuticals | 351.51B |
| Rubicon Research | 224.36B |
| AstraZeneca Pharma India | 210.17B |